THAILAND

Edwards Unveils Breakthrough Valve Repair System in Thailand

Published on 10/06/2025

» Bangkok, June 9, 2025: In an era of continuous advancements in medical technology, Edwards Lifesciences (NYSE: EW), a global leader in patient-focused innovations for structural heart disease, has announced a significant breakthrough with the launch of its Transcatheter Mitral Valve Repair System in Thailand. This system provides a new treatment option for patients suffering from mitral regurgitation (MR), which is one of the most common valvular heart diseases, affecting more than 175 million people worldwide in 2023, as reported by the U.S. National Center for Biotechnology Information (NCBI).